Causal pathways of plasma metabolites: unveiling metabolic associations in liver diseases
Xiaoxuan He, Yanfen Ma, Qian Wu, Jing Feng, Wei Wang, Shan Zhao, Xiaoqin Wang

TL;DR
This study identifies causal links between plasma metabolites and liver diseases, highlighting the role of glucose metabolism in conditions like fibrosis and liver cancer.
Contribution
The study uses Mendelian randomization to uncover novel causal associations between specific metabolites and chronic liver diseases.
Findings
252 potential causal associations were identified between plasma metabolites and liver diseases, with 13 showing strong effects.
An elevated glucose-to-mannose ratio was significantly linked to fibrosis/cirrhosis, metabolic liver disease, and hepatoma.
Six metabolites increased fibrosis/cirrhosis risk, while three were associated with liver cancer.
Abstract
This study aimed to explore the causal relationships between 1,400 plasma metabolites and various chronic liver conditions, including liver fibrosis or cirrhosis, liver carcinoma, hepatic failure, and metabolic liver disorders. This study used a two-sample Mendelian randomization (MR) method. Forward analysis focused on associations with four liver disease categories, whereas reverse analysis examined links with specific metabolites or ratios. Five MR methods were applied, primarily the inverse variance weighted (IVW) method. The IVW, Egger, and Weighted Median analyses showed p-values < 0.05 with positive directions, suggesting strong positive effects. The IVW analysis alone indicated a potential positive effect with p-value < 0.05. Sensitivity analyses ensured the results’ robustness and validity. In the forward causal analysis, we identified 252 potential causal associations, 13 of…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2
Figure 3
Figure 4
Figure 5Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsLiver Disease Diagnosis and Treatment · Metabolomics and Mass Spectrometry Studies · Diabetes, Cardiovascular Risks, and Lipoproteins
